Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Medical Informatics

Date Submitted: Nov 6, 2021
Date Accepted: Feb 25, 2022

The final, peer-reviewed published version of this preprint can be found here:

A Clinical Decision Support System for Assessing the Risk of Cervical Cancer: Development and Evaluation Study

Chekin N, Ayatollahi H, Karimi Zarchi M

A Clinical Decision Support System for Assessing the Risk of Cervical Cancer: Development and Evaluation Study

JMIR Med Inform 2022;10(6):e34753

DOI: 10.2196/34753

PMID: 35731549

PMCID: 9260527

A Clinical Decision Support System for Assessing the Risk of Cervical Cancer

  • Nasrin Chekin; 
  • Haleh Ayatollahi; 
  • Mojgan Karimi Zarchi

ABSTRACT

Background:

Cervical cancer has been recognized as a preventable cancer. As the assessment of all risk factors of diseases is challenging for physicians, information technology and risk assessment models have been employed to estimate the degree of risk.

Objective:

The aim of the present study was to develop a clinical decision support system to assess the risk of cervical cancer.

Methods:

This study was conducted in two phases in 2021. In the first phase of the study, 20 gynecologists completed a questionnaire to determine the essential parameters for assessing the risk of cervical cancer and the data were analyzed using descriptive statistics. In the second phase of the study, the prototype of the clinical decision support system was developed and evaluated.

Results:

The findings revealed that the most important parameters for assessing the risk of cervical cancer consisted of general and specific parameters. In total, eight parameters that had the greatest impact on the risk of cervical cancer were selected. After developing the clinical decision support system, it was evaluated and the mean values of sensitivity, specificity, and accuracy for the system were 85.81%, 93.82%, and 91.39%, respectively.

Conclusions:

It appears that the clinical decision support system developed in this study can facilitate the process of identifying individuals at the risk of cervical cancer. In addition, it is expected to increase the quality of health care and reduce the costs associated with the treatment of cervical cancer by taking advantage of the developed clinical decision support system.


 Citation

Please cite as:

Chekin N, Ayatollahi H, Karimi Zarchi M

A Clinical Decision Support System for Assessing the Risk of Cervical Cancer: Development and Evaluation Study

JMIR Med Inform 2022;10(6):e34753

DOI: 10.2196/34753

PMID: 35731549

PMCID: 9260527

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.